AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 201 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,000 | -25.0% | 121 | 0.0% | 0.00% | – |
| Q1 2022 | $4,000 | 0.0% | 121 | 0.0% | 0.00% | – |
| Q4 2021 | $4,000 | -88.2% | 121 | -83.4% | 0.00% | – |
| Q3 2021 | $34,000 | -78.9% | 727 | -75.2% | 0.00% | – |
| Q2 2021 | $161,000 | -54.4% | 2,927 | -57.2% | 0.00% | – |
| Q1 2021 | $353,000 | -65.3% | 6,845 | -70.8% | 0.00% | -100.0% |
| Q4 2020 | $1,017,000 | -42.2% | 23,480 | -28.6% | 0.00% | -50.0% |
| Q2 2020 | $1,759,000 | -32.7% | 32,886 | -55.4% | 0.00% | -42.9% |
| Q1 2020 | $2,614,000 | -40.7% | 73,686 | -20.2% | 0.01% | -22.2% |
| Q4 2019 | $4,411,000 | +233.7% | 92,386 | +126.4% | 0.01% | +200.0% |
| Q3 2019 | $1,322,000 | +21.7% | 40,805 | +87.5% | 0.00% | +50.0% |
| Q2 2019 | $1,086,000 | -61.5% | 21,766 | -55.8% | 0.00% | -60.0% |
| Q4 2017 | $2,818,000 | -8.0% | 49,300 | +7.4% | 0.01% | -16.7% |
| Q3 2017 | $3,064,000 | +23.8% | 45,900 | -4.6% | 0.01% | 0.0% |
| Q2 2017 | $2,475,000 | +39.0% | 48,100 | +57.7% | 0.01% | +20.0% |
| Q1 2017 | $1,781,000 | +252.7% | 30,500 | +152.1% | 0.01% | +150.0% |
| Q4 2016 | $505,000 | -34.1% | 12,100 | -16.6% | 0.00% | -33.3% |
| Q3 2016 | $766,000 | +66.2% | 14,500 | +31.8% | 0.00% | +50.0% |
| Q2 2016 | $461,000 | +2.2% | 11,000 | -0.9% | 0.00% | 0.0% |
| Q1 2016 | $451,000 | -2.2% | 11,100 | +56.3% | 0.00% | 0.0% |
| Q4 2015 | $461,000 | +723.2% | 7,100 | +787.5% | 0.00% | – |
| Q3 2015 | $56,000 | -16.4% | 800 | +33.3% | 0.00% | – |
| Q2 2015 | $67,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |